MENU
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Passage Bio (PASG) Ownership - Who owns Passage Bio?
Profile
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.77M
P/E Ratio
N/A
Total Cash
84.83M
Projected Growth
N/A
Total Debt
25.82M
Revenue
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
1.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PASG
Capitalization
40.8M
P/E Ratio
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash
84.8M
Total Cash/Share
1.37
Total Debt
25.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
72.7M
P/B Ratio
0.56
Cash Flow
N/A
Earnings
-1.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
5.15
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-66.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.97
Shares Held By Institutions
24.1M
Shares Outstanding - Current
61.8M
Total Liabilities
39M
Total Volume MTD
N/A
Value
1
Gain YTD
-35.248
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com